FindTrial
Sign In

A study to view the effects of a drug Levobupivacaine, used to provide muscle paralysis and insensitivity to pain in surgeries .

" A study of clinical effects of 0.5% hyperbaric levobupivacaine for spinal Anaesthesia."

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/10/058526
Enrollment
50
Registered
2023-10-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: hyperbaric levobupivacaine 0.5%: hyperbaric levobupivacaine 0.5% is a drug injecting intrathecally in spinal anaesthesia procedure

Sponsors

Dr B R Ambedkar medical College and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A)All patients aged between 18 to 60 years of age posted for elective surgeries under spinal anaesthesia. b) ASA grade I and II patient

Exclusion criteria

Exclusion criteria: patients with bleeding and coagulation disorders and local site infections are excluded.

Design outcomes

Primary

MeasureTime frame
To study the total duration of analgesia with intrathecal 0.5% hyperbaric levobupivacaine.Timepoint: every two hours—

Secondary

MeasureTime frame
1) Sensory Block a) Maximum height of block achieved b) Time to maximum sensory block 2) Motor block a) Time of Maximum Motor Block b) Time to complete motor recovery. 3) To assess side effects if any 1) Hypotension 2) Bradycardia 3) Nausea 4) Vomiting Timepoint: 24 hrs—

Countries

India

Contacts

Public ContactDR VISHNU VC

Dr BR Ambedkar Medical College, Bengaluru

drsalim_iqbal@yahoo.co.in9964651079

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026